Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Nov;4(4):665-669.
doi: 10.1002/ehf2.12178. Epub 2017 Jul 4.

Contrast-enhanced computed tomography with myocardial three-dimensional printing can guide treatment in symptomatic hypertrophic obstructive cardiomyopathy

Affiliations
Case Reports

Contrast-enhanced computed tomography with myocardial three-dimensional printing can guide treatment in symptomatic hypertrophic obstructive cardiomyopathy

Yasuhiro Hamatani et al. ESC Heart Fail. 2017 Nov.

Abstract

Both surgical myectomy and percutaneous transluminal septal myocardial ablation are effective treatments for drug-refractory symptomatic hypertrophic obstructive cardiomyopathy (HOCM). However, in some cases, it is not easy to elucidate the abnormal structure of left ventricular outflow obstruction to adopt these treatments. Here, we presented a young female patient with drug-refractory symptomatic HOCM. In this case, contrast-enhanced computed tomography enabled us to assess the suitability of percutaneous transluminal septal myocardial ablation. By creating three-dimensional printed models using computed tomography data, we could also visualize intracardiac structure and simulate the surgical procedure. A multimodality assessment strategy is useful for evaluating patients complicated with drug-refractory symptomatic HOCM.

Keywords: 3D printing; Hypertrophic obstructive cardiomyopathy; Surgical myectomy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Coronary angiography and computed tomographic short axis view. (A) Right anterior oblique cranial view. (B) Right anterior oblique caudal view. White arrow indicates the first septal branch, and black arrow indicates the second septal branch. (C) The first septal branch (white arrow) supplies the myocardium related to the left ventricular outflow tract obstruction. (D) The second septal branch (black arrow) supplies the myocardium at the inferior‐posterior mid portion.
Figure 2
Figure 2
Transesophageal echocardiography before surgery. (A) Systolic anterior motion of the mitral valve, and mitral valve leaflet‐septal contact were observed (white arrow). (B) Relatively thin septal wall (maximum wall thickness 17 mm) was observed (black arrow). (C) Severe mitral regurgitation and acceleration flow at the left ventricular outflow tract were observed. (D) Abnormal chordae were observed (yellow arrow). Ao, aorta; LA, left atrium; LV, left ventricle; RA, right atrium; RV, right ventricle.
Figure 3
Figure 3
Three‐dimensional (3D) printed model of hypertrophic obstructive cardiomyopathy. (A) through (B) 3D printing showed left ventricle geometry. (C) Intracardiac geometry. Black arrow shows abnormally thickened chordae. (D) Simulation of myectomy using 3D printed model.
Figure 4
Figure 4
Intraoperative photography. (A) The view is from the aortic side looking into the left ventricle. The surgeon is cutting the septal myocardium using a surgical scalpel. Hypertrophied septal wall was resected. (B) Abnormal chordae were also resected (black arrow). (C) Plication of posterior mitral valve was performed (white arrow).

Similar articles

Cited by

References

    1. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2733–2779. - PubMed
    1. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 124: 2761–2796. - PubMed
    1. Maron BJ, Nishimura RA. Surgical septal myectomy versus alcohol septal ablation: assessing the status of the controversy in 2014. Circulation 2014; 130: 1617–1624. - PubMed
    1. Ghersin E, Soto V, Heldman AW. Multidetector computerized tomography can guide and document alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 2011; 123: e5–e7. - PubMed
    1. Spratt JC, Langrish JP. Identifying the target septal perforator prior to alcohol septal ablation in hypertrophic obstructive cardiomyopathy: a new application for computed tomography coronary angiography. Heart 2011; 97: 1718–1719. - PubMed

Publication types

MeSH terms